| P2093 | author name string | Gail V W Johnson | |
| | Julianne Feola | |
| | Laura Yunes-Medina | |
| P2860 | cites work | Cytosolic guanine nucledotide binding deficient form of transglutaminase 2 (R580a) potentiates cell death in oxygen glucose deprivation | Q21560855 |
| | Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin | Q24680821 |
| | Transglutaminase 2: an enigmatic enzyme with diverse functions | Q28205648 |
| | Cellular functions of tissue transglutaminase | Q28260600 |
| | Intracellular localization and conformational state of transglutaminase 2: implications for cell death | Q33476870 |
| | Transglutaminase regulation of cell function. | Q33707936 |
| | Vascular events after spinal cord injury: contribution to secondary pathogenesis | Q33951619 |
| | Astrocyte-derived tissue transglutaminase interacts with fibronectin: a role in astrocyte adhesion and migration? | Q34031863 |
| | Characterization of distinct sub-cellular location of transglutaminase type II: changes in intracellular distribution in physiological and pathological states | Q34517980 |
| | Transglutaminases: crosslinking enzymes with pleiotropic functions | Q35058528 |
| | Extracellular TG2: emerging functions and regulation | Q35587161 |
| | Transglutaminase 2: a molecular Swiss army knife | Q35693361 |
| | Pathophysiology of stroke: lessons from animal models | Q35956294 |
| | Transglutaminase inhibition protects against oxidative stress-induced neuronal death downstream of pathological ERK activation | Q36241237 |
| | Transglutaminase and polyamination of tubulin: posttranslational modification for stabilizing axonal microtubules | Q36768195 |
| | Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling | Q36804922 |
| | Extracellular tissue transglutaminase activates noncanonical NF-κB signaling and promotes metastasis in ovarian cancer | Q36879220 |
| | Tissue transglutaminase promotes or suppresses tumors depending on cell context. | Q37520382 |
| | Transglutaminase 2 modulation of NF-κB signaling in astrocytes is independent of its ability to mediate astrocytic viability in ischemic injury | Q38682039 |
| | Appearance of tissue transglutaminase in astrocytes in multiple sclerosis lesions: a role in cell adhesion and migration? | Q39664398 |
| | Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells | Q39786229 |
| | Intracellular localization and activity state of tissue transglutaminase differentially impacts cell death | Q40608257 |
| | Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia | Q40998895 |
| | Reduced expression of tissue transglutaminase in a human endothelial cell line leads to changes in cell spreading, cell adhesion and reduced polymerisation of fibronectin. | Q41074541 |
| | Transglutaminase 2 facilitates or ameliorates HIF signaling and ischemic cell death depending on its conformation and localization | Q42403952 |
| | Transglutaminase 2 protects against ischemic stroke | Q42563371 |
| | A novel RGD-independent cel adhesion pathway mediated by fibronectin-bound tissue transglutaminase rescues cells from anoikis | Q42802185 |
| | Cell surface localization of tissue transglutaminase is dependent on a fibronectin-binding site in its N-terminal beta-sandwich domain | Q42809903 |
| | Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: effects on cellular morphology and adhesion | Q42816111 |
| | Increased expression of tissue-type transglutaminase following middle cerebral artery occlusion in rats | Q44899092 |
| | Transglutaminase activity and transglutaminase mRNA transcripts in gerbil brain ischemia | Q44917306 |
| | Expression of tissue-type transglutaminase (tTG) and the effect of tTG inhibitor on the hippocampal CA1 region after transient ischemia in gerbils | Q46050087 |
| | Cell death in primary cultures of mouse neurons and astrocytes during exposure to and 'recovery' from hypoxia, substrate deprivation and simulated ischemia | Q48171569 |
| | Inhibition or ablation of transglutaminase 2 impairs astrocyte migration. | Q48412795 |
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | astrocyte | Q502961 |
| P304 | page(s) | 1208-1214 | |
| P577 | publication date | 2017-09-27 | |
| P1433 | published in | NeuroReport | Q15710007 |
| P1476 | title | Subcellular localization patterns of transglutaminase 2 in astrocytes and neurons are differentially altered by hypoxia | |
| P478 | volume | 28 | |